News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Nicolas Hart: Our New Paper, Led by Takemura Naomi – Introducing the ‘Treatable Traits’ Paradigm to Cancer Care
Nicolas Hart and Takemura Naomi
Jun 25, 2025, 23:20

Nicolas Hart: Our New Paper, Led by Takemura Naomi – Introducing the ‘Treatable Traits’ Paradigm to Cancer Care

Nicolas Hart, Associate Professor and Program Director at University of Technology Sydney, shared a post on X:

“Our new paper, led by MASCC Survivorship Fellow, Takemura Naomi – introducing the ‘treatable traits’ paradigm to cancer care.
A treatable trait must:
1. Have Clinical Relevance.
2. Identifiable and Measurable.
3. Evidence-based Interventions.”

Nicolas Hart

Title: Treatable traits in cancer: expanding the paradigm to people with diagnosed malignancies

Journal: Supportive Care in Cancer

Authors: Naomi Takemura, Vanessa M. McDonald, Nicolas H. Hart, Janelle Yorke

Read the full article.

Nicolas Hart

More posts featuring Nicolas Hart on OncoDaily.

cancer Janelle Yorke MASCC Survivorship Fellow Naomi Takemura Nicolas H. Hart. Nicolas Hart OncoDaily Oncology Supportive Care in Cancer Takemura Naomi University of Technology Sydney Vanessa M. McDonald
Special Coverage
Insight
Jun 25, 2025, 23:20
Nicolas Hart: Our New Paper, Led by Takemura Naomi - Introducing the ‘Treatable Traits’ Paradigm to Cancer Care
Insight
Jun 25, 2025, 23:03
Cristiane D Bergerot: How Does Cancer-related Distress Differ Between Brazil and Mexico?
Blog
Jun 25, 2025, 22:49
Darcy Burbage: On My Way to Seattle for MASCC25
Opinion
Jun 25, 2025, 22:05
Supriya Peshin Shared Details on The 2025 Portland Cholangiocarcinoma Symposium
Blog
Jun 25, 2025, 21:21
Galip Can Uyar: Ovarian Cancer Treatment Is Entering a New Era
Blog
Jun 25, 2025, 21:00
Pillar 3 of the National Cancer Control Strategy, 2023-2027: Cancer Treatment, Palliative Care and Survivorship - NCI Kenya
Insight
Jun 25, 2025, 20:47
Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC
Career
Jun 25, 2025, 20:30
NFCR Awarded 2025 Szent-Györgyi Prize to Anthony R. Hunter for Progress in Cancer Research
Insight
Jun 25, 2025, 17:58
Shankar Siva: We Randomised the Final Patient on TROG Cancer Research 19.06 DECREASE Trial
Blog
Jun 25, 2025, 17:39
Julie Gralow: Pleased to Participate in This Well-organized Best of ASCO UAE Program in Abu Dhabi
Science
Jun 25, 2025, 16:50
Cedric Blanpain Shares New Study on the Role of Innate Immunity in Regulating Cell Plasticity and Reprogramming of Prostate Tumor Initiating Cells
Blog
Jun 25, 2025, 16:24
Results From Amgen's Phase 2 Obesity Study of Monthly Maritide Presented at the American Diabetes Association 85th Scientific Sessions